Stock Based Compensation (Tables)

3 Months Ended

Dec. 31, 2018

Schedule Of Stock Compensation Expense [Table Text Block]

Stock compensation expense for the three months ended December 31, 2018 and 2017 is as follows:

	Three Months Ended		Three Months Ended
Stock Compensation Expense	December 31, 2018		December 31, 2017
Stock grants	$	51,000	$	39,000
Restricted stock grants		15,000		13,000
Option grants		-		12,000
Employee stock purchase plan		1,000		1,000
Subsidiary option grants		11,000		28,000
Total	$	78,000	$	93,000

Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]

A summary of restricted stock activity for the three months ended December 31, 2018 is presented below:

Restricted Stock Activity for the Three Months ended December 31, 2018	Shares			Weighted-Average Grant-Date Fair Value
Nonvested at September 30, 2018		60,000		$	1.61
Granted		-
Vested		(10,000	)	$	1.70
Cancelled		-			-
Nonvested and expected to vest at December 31, 2018		50,000		$	1.59

Stock Option Grants [Member]

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]

During the three months ended December 31, 2018, no Dynasil stock options were granted. A summary of stock option activity for the three months ended December 31, 2018 is presented below:

	Options Outstanding		Weighted Average Exercise Price per Share		Weighted Average Remain Contractual Term (in Years)
Balance at September 30, 2018		160,537	$	2.01		0.93
Outstanding and exercisable at September 30, 2018		160,537	$	2.01		0.93
Granted		-		-
Exercised		-		-
Cancelled		-		-
Balance at December 31, 2018		160,537	$	2.01		0.68
Outstanding and exercisable at December 31, 2018		160,537	$	2.01		0.68

Subsidiary Option Grants [Member]

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]

During the three months ended December 31, 2018, no Xcede stock options were granted. A summary of Xcede stock option activity for the three months ended December 31, 2018 is presented below:

	Options Outstanding		Weighted Average Exercise Price per Share		Weighted Average Remain Contractual Term (in Years)
Balance at September 30, 2018		1,300,956	$	1.00		7.31
Outstanding and exercisable at September 30, 2018		1,229,685		1.00		7.11
Granted		-		-
Exercised		-		-
Cancelled		-		-
Balance at December 31, 2018		1,300,956		1.00		6.85
Outstanding and exercisable at December 31, 2018		1,248,384	$	1.00		6.85